Clinical Research

Study on risk factors of colorectal adenomatous polyps and construction and validation of prediction model

  • Kui DONG ,
  • jie WU ,
  • Jing YAN ,
  • Haitao LIU ,
  • Jun WANG ,
  • Guan′en. QIAO
Expand
  • Department of Gastroenterology,the First Hospital of Handan,Handan 056000,Hebei,China

Received date: 2024-10-20

  Online published: 2025-03-31

Abstract

Objective To identify risk factors for colorectal adenomatous polyps using logistic regression analysis, construct a prediction model based on these identified factors, and subsequently evaluate the performance of the model. Methods Encompassed 1,023 patients who underwent large intestine polyp resection at the First Hospital of Handan between January 2017 and January 2022. Among these patients, 676 had adenomatous polyps (adenomatous polyp group) and 347 had non-adenomatous polyps (non-adenomatous polyp group). We collected data on basic information, medical history, colonoscopy results, and polyp pathology. By comparing the two groups, we identified significant differences in various indicators, which were selected as candidate factors for model construction. Patients were randomly divided into a training set and a validation set at an 8∶2 ratio. Using the training set data, we constructed a risk prediction model and developed a nomogram using R Studio software to visually present the model. Finally, we internally validated the model using the validation set. The model's discrimination ability was evaluated using the ROC curve, its accuracy was assessed via the calibration curve, and its clinical utility was evaluated through decision curve analysis (DCA). Results Significant differences were observed between the two groups in terms of age, drinking habits, family history of colorectal cancer, hyperlipidemia, history of cholecystectomy, HP infection, and history of appendectomy (P < 0.05). These variables were included in the model construction. A total of 818 participants were randomly assigned to the training set, while 205 were allocated to the validation set. Multivariate logistic regression analysis on the training set confirmed that age (OR = 1.021, 95%CI: 1.006 ~ 1.036, P = 0.006), alcohol consumption (OR = 3.440, 95%CI: 2.251 ~ 5.257, P < 0.001), first-degree relatives with colorectal cancer (OR = 3.775, 95%CI: 1.881 ~ 7.577, P < 0.001), hyperlipidemia (OR = 3.428, 95%CI: 2.443 ~ 4.808, P < 0.001), history of cholecystectomy (OR = 3.916, 95%CI: 1.756 ~ 8.735, P < 0.001), Helicobacter pylori (HP) infection (OR = 3.292, 95%CI: 2.309 ~ 4.693, P < 0.001), and history of appendectomy (OR = 3.819, 95%CI: 2.002 ~ 7.286, P < 0.001) were independent risk factors for adenomatous polyps. Consequently, a prediction model for large intestine adenomatous polyps was developed using the formula P = 1/(1+e-Y), where Y = 0.020 × age + 1.328 × first-degree relatives with colorectal cancer + 1.235 × alcohol consumption + 1.232 × hyperlipidemia + 1.365 × cholecystectomy + 1.192 × HP infection + 1.340 × appendectomy - 1.995. The model demonstrated good performance with AUC values of 0.763 (95%CI: 0.729 ~ 0.797) for the training set and 0.769 (95%CI: 0.644 ~ 0.787) for the validation set. The calibration curve indicated a good fit, and decision curve analysis showed that the model could achieve positive net benefit across a wide range of threshold probabilities, confirming its clinical utility. Conclusions Age, alcohol consumption, a family history of colorectal cancer in first-degree relatives, hyperlipidemia, cholecystectomy, HP infection, and appendectomy were identified as independent risk factors for adenomatous polyps. A prediction model incorporating these risk factors holds significant practical value for predicting the occurrence of colorectal adenomatous polyps.

Cite this article

Kui DONG , jie WU , Jing YAN , Haitao LIU , Jun WANG , Guan′en. QIAO . Study on risk factors of colorectal adenomatous polyps and construction and validation of prediction model[J]. The Journal of Practical Medicine, 2025 , 41(6) : 838 -845 . DOI: 10.3969/j.issn.1006-5725.2025.06.010

References

1 SNINSKY J A, SHORE B M, LUPU G V, et al. Risk Factors for Colorectal Polyps and Cancer [J]. Gastrointest Endosc Clin N Am, 2022, 32(2): 195-213. doi:10.1016/j.giec.2021.12.008
2 SUNG H, FERLAY J, SIEGEL R L, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries [J]. CA Cancer J Clin, 2021, 71(3): 209-249. doi:10.3322/caac.21660
3 LIN J S, PERDUE L A, HENRIKSON N B, et al. Screening for Colorectal Cancer: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force [J]. JAMA, 2021, 325(19): 1978-1998. doi:10.1001/jama.2021.4417
4 中华医学会病理学分会消化疾病学组. 胃肠道腺瘤和良性上皮性息肉的病理诊断共识 [J]. 中华病理学杂志, 2020, 49(1): 3-11.
5 国家消化系统疾病临床医学研究中心, 国家消化道早癌防治中心联盟, 中华医学会消化内镜学分会, 等. 中国早期结直肠癌筛查流程专家共识意见(2019,上海) [J]. 中华内科杂志, 2019, 58(10): 736-744.
6 秦影, 申星杰, 刘亮, 等. 结直肠腺瘤性息肉发病危险因素分析及预测模型构建 [J]. 山东医药, 2022, 62(21): 58-61.
7 张旭航, 路德荣. 结直肠腺瘤性息肉发生风险预测模型的建立与验证 [J]. 胃肠病学和肝病学杂志, 2024, 33(1): 65-69.
8 O'SULLIVAN D E, SUTHERLAND R L, TOWN S, et al. Risk Factors for Early-Onset Colorectal Cancer: A Systematic Review and Meta-analysis [J]. Clin Gastroenterol Hepatol, 2022, 20(6): 1229-1240.e5. doi:10.1016/j.cgh.2021.01.037
9 RUBIN-GARCIA M, MARTIN V, VITELLI-STORELLI F, et al. Family history of first degree as a risk factor for colorectal cancer [J]. Gac Sanit, 2022, 36(4): 345-352.
10 周海萍, 沈忠磊, 赵坚培, 等. 结直肠腺瘤分布特征及危险因素分析 [J]. 中华胃肠外科杂志, 2018, 21(6): 678-684.
11 张杰. 胆囊结石规范化诊治的现状与争议 [J]. 中国微创外科杂志, 2022, 22(10): 829-833.
12 中华医学会外科学分会胆道外科学组, 中国医师协会外科医师分会胆道外科医师委员会. 胆囊良性疾病外科治疗的专家共识(2021版) [J]. 中华外科杂志, 2022, 60(1): 4-9.
13 OCVIRK S, O'KEEFE S J D. Dietary fat, bile acid metabolism and colorectal cancer [J]. Semin Cancer Biol, 2021, 73: 347-355. doi:10.1016/j.semcancer.2020.10.003
14 LIU T, SONG X, KHAN S, et al. The gut microbiota at the intersection of bile acids and intestinal carcinogenesis: An old story, yet mesmerizing [J]. Int J Cancer, 2020, 146(7): 1780-1790. doi:10.1002/ijc.32563
15 VANELLA G, ARCHIBUGI L, STIGLIANO S, et al. Alcohol and gastrointestinal cancers [J]. Curr Opin Gastroenterol, 2019, 35(2): 107-113. doi:10.1097/mog.0000000000000502
16 ZHU J Z, WANG Y M, ZHOU Q Y, et al. Systematic review with meta-analysis: Alcohol consumption and the risk of colorectal adenoma [J]. Aliment Pharmacol Ther, 2014, 40(4): 325-337. doi:10.1111/apt.12841
17 中华医学会消化病学分会, 中华医学会消化病学分会消化系统肿瘤协作组. 中国结直肠肿瘤综合预防共识意见(2021年,上海) [J]. 胃肠病学, 2021, 26(5): 279-311.
18 ARNONE D, CHABOT C, HEBA A C, et al. Sugars and Gastrointestinal Health [J]. Clin Gastroenterol Hepatol, 2022, 20(9): 1912-1924.e1917. doi:10.1016/j.cgh.2021.12.011
19 汤明欣, 王晓林, 李炫飞. 他汀类药物在结直肠癌防治中的研究进展 [J]. 实用医学杂志, 2024, 40(14): 2041-2046.
20 GIOVANNUCCI E. Insulin, insulin-like growth factors and colon cancer: A review of the evidence [J]. J Nutr, 2001, 131(11 ): 3109S-3120S. doi:10.1093/jn/131.11.3109s
21 王东洋. FGF19/FGFR4与高脂血症促结直肠腺瘤发生及癌变机制的研究 [D]. 济南:山东大学,2019.
22 中华医学会消化病学分会幽门螺杆菌学组. 第六次全国幽门螺杆菌感染处理共识报告(非根除治疗部分) [J]. 中华消化杂志, 2022, 42(5): 289-303.
23 庄肇朦, 陈怡, 余炳取, 等. 高毒力幽门螺杆菌感染对结直肠腺瘤患者血清胃泌素、胃动素表达及预后的影响 [J]. 重庆医学, 2022, 51(13): 2203-2207.
24 李欣, 霍丽娟. 幽门螺杆菌感染与结直肠腺瘤相关性的研究进展 [J]. 国际消化病杂志, 2021, 41(6): 414-417.
25 GAO J L, WANG X H, MA Z Q, et al. Expression of Cyclooxygenase-2 in Patients With Snow-White Sign of Advanced Colorectal Adenomas [J]. Acta Academiae Medicinae Sinicae, 2023, 45(4): 591-596.
26 魏以召, 常玉英, 谢静. 幽门螺杆菌感染与结肠息肉、结肠癌的相关性 [J]. 实用医学杂志, 2019, 35(7): 1120-1123.
27 WU S C, CHEN W T, MUO C H, et al. Association between appendectomy and subsequent colorectal cancer development: An Asian population study [J]. PLoS One, 2015, 10(2): e0118411. doi:10.1371/journal.pone.0118411
28 ESPOSITO F, PRETE M D, MAGRI M, et al. Colorectal screening following appendectomy in adult patients: A systematic review [J]. Ann Coloproctol, 2024, 40(5): 417-423. doi:10.3393/ac.2023.00528.0075
29 PARK Y Y, LEE K Y, OH S T, et al. A link between appendectomy and gastrointestinal cancers: A large-scale population-based cohort study in Korea [J]. Sci Rep, 2020, 10(1): 15670. doi:10.1038/s41598-020-72770-5
30 王淘淘, 刘妍, 张毕方, 等. 内镜逆行阑尾炎治疗术:阑尾炎治疗的新选择 [J]. 现代消化及介入诊疗, 2022, 27(3): 379-382,378.
Outlines

/